https://www.thebodypro.com/article/monthly-long-acting-injectable-hiv-meds-studies
HIV Treatments in DevelopmentNews

Monthly Long-Acting Injectable HIV Meds Just as Good as Daily Pill for Those New to Treatment and Those Already Undetectable, New Studies Find

injectable
MarianVejcik via iStock
    • Orkin C, et al "Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection (FLAIR Study)" N Engl J Med 2020; DOI: 10.1056/NEJMoa1909512.

    • Swindells S, et al "Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression (ATLAS Trial)" N Engl J Med 2020; DOI: 10.1056/NEJMoa1904398.

    • Currier J "Monthly Injectable Antiretroviral Therapy -- Version 1.0 of a New Treatment Approach" N Engl J Med 2020; DOI: 10.1056/NEJMe2002199.

    Kenyon Farrow

    Kenyon Farrow

    @kenyonfarrow

    Kenyon was the senior editor of TheBody/TheBodyPro from 2017 to 2020. He is the co-executive director of Partners for Dignity & Rights, a U.S. organization advocating for social and systemic justice.